Over-the-counter use of short-acting beta-2 agonists: a systematic review.

ABSTRACT:

Background

The widespread use of short-acting beta-2 agonists (SABA) as an as-needed treatment for asthma is well-established. However, excessive use of SABA has been linked to undesirable outcomes such as increased risk of asthma attacks, exacerbations, and even death. The availability of SABA as an over-the-counter (OTC) medication has contributed to their overuse, leading to undertreated asthma and reduced access to asthma education.

Objective

This systematic review aimed to summarize the prevalence, characteristic features of, and factors contributing to over-the-counter SABA purchase or overuse.

Methods

The databases searched included PubMed, Scopus, Springer Link, Google Scholar, CINAHL, and APA PsycArticles. Original research articles reporting the prevalence,

SUBMITTER: Loh ZC 

PROVIDER: S-EPMC10561505 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature